1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Kuwait Pharmaceuticals and Healthcare Report Q4 2016

Kuwait Pharmaceuticals and Healthcare Report Q4 2016

  • September 2016
  • -
  • Business Monitor International
  • -
  • 88 pages

Includes 3 FREE quarterly updates


BMI View: The gradual economic recovery will support the government's plans within the healthcare sector; however, political instability poses the greatest risk to our outlook. Kuwait's political backdrop is complicated by labour and population imbalances, as well as a parliament which has consistently blocked the government's reform efforts. While these healthcare reforms are still likely to be implemented, changes to the election law reform mean they are vulnerable to lengthy delays as political tensions continue to elevate.

Headline Expenditure Projections
- Pharmaceuticals: From KWD300mn (USD1.0bn) in 2015 to KWD310mn (USD1.03bn) in 2016; +4.9% in local currency terms and +2.9% in US dollar terms. Forecast revised downward from Q316.
- Healthcare: From KWD1.61bn (USD5.34bn) in 2015 to KWD1.74bn (USD5.68bn) in 2016; +8.4% in local currency terms and +6.3% in US dollar terms. Forecast revised downward from Q316.

Table Of Contents

Kuwait Pharmaceuticals and Healthcare Report Q4 2016
BMI Industry View 7
Table: Headline Pharmaceuticals and Healthcare Forecasts (Kuwait 2014-2020) 7
SWOT 9
Industry Forecast 12
Pharmaceutical Market Forecast 12
Table: Pharmaceutical Sales, Historical Data And Forecasts (Kuwait 2012-2020) 14
Healthcare Market Forecast 15
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Kuwait 2012-2020) 17
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Kuwait 2012-2020) 17
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Kuwait 2012-2020) 17
Prescription Drug Market Forecast 18
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Kuwait 2012-2020) 19
Patented Drug Market Forecast 20
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Kuwait 2012-2020) 22
Generic Medicines Market Forecast 23
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Kuwait 2012-2020) 25
OTC Medicines Market Forecast 26
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Kuwait 2012-2020) 27
Pharmaceutical Trade Forecast 28
Table: Pharmaceutical Trade Data And Forecasts (Kuwait 2014-2020) 30
Table: Pharmaceutical Trade Data And Forecasts local currency (Kuwait 2014-2020) 30
Industry Risk Reward Index 31
Middle East and Africa Risk/Reward Index - Q4 2016 31
Kuwait Risk/Reward Index 39
Rewards 39
Risks 40
Regulatory Review 41
Intellectual Property Issues 43
Pricing Regime 44
Reimbursement Regime 46
Market Overview 51
Healthcare Sector 51
Clinical Trials 58
Epidemiology 59
Competitive Landscape 63
Research-Based Industry 63
Table: Multinational Company Activity 64
Pharmaceutical Distribution 65
Pharmaceutical Retail Sector 65
Company Profile 67
Advanced Technology Company 67
Bader Sultan and Bros 70
Kuwait-Saudi Pharmaceutical Industries (KSP) 73
Safwan Trading And Contracting Company 75
Demographic Forecast 77
Table: Population Headline Indicators (Kuwait 1990-2025) 78
Table: Key Population Ratios (Kuwait 1990-2025) 78
Table: Urban/Rural Population and Life Expectancy (Kuwait 1990-2025) 79
Table: Population By Age Group (Kuwait 1990-2025) 79
Table: Population By Age Group % (Kuwait 1990-2025) 80
Glossary 82
Methodology 84
Pharmaceutical Expenditure Forecast Model 84
Healthcare Expenditure Forecast Model 84
Notes On Methodology 85
Risk/Reward Index Methodology 86
Index Overview 87
Table: Pharmaceutical Risk/Reward Index Indicators 87
Indicator Weightings 88

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Prostate Cancer Pricing, Reimbursement, and Access

Prostate Cancer Pricing, Reimbursement, and Access

  • $ 7 500
  • Industry report
  • July 2016
  • by Datamonitor Healthcare

Novel antiandrogens will need to present risk-sharing agreements in EU markets, while discussing contracting with US payers to ensure a competitive advantage. Vaccines suffer from inconclusive response ...

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

  • $ 7 000
  • Industry report
  • August 2016
  • by Frost & Sullivan

Emerging Business Models Drive Transformation The key objective of this research is to provide in-depth knowledge of the major global pharmaceutical CMO market segments—active pharmaceutical ingredients ...

IMS World Review Executive™ 2016

IMS World Review Executive™ 2016

  • $ 6 860
  • Industry report
  • July 2016
  • by IMS Health

IMS World Review ExecutiveTM 2016 provides essential insights into worldwide sales of the pharmaceutical market, interlocking market trends and sales analysis from 2011 to 2015, including the breakdown ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.